)
)
)
Gunner Hardy
Senior Associate
,
BOLD Longevity Growth Fund
Gunner Laine Hardy is a Senior Associate at BOLD Longevity Growth Fund (BLG), where he focuses on growth stage investments in biotechnology, longevity therapeutics, and AI driven drug development platforms. At BLG, he leads diligence across clinical pipelines and therapeutic modalities, evaluating upstream disease drivers and platform scalability. Prior to joining BLG, Gunner was a Venture Partner at Conscience VC, supporting early stage investments at the intersection of science and consumer health. He previously served as a Senior Associate at Longevity Vision Fund, one of the earliest dedicated longevity focused venture funds, investing across Series B to crossover rounds in gene editing, regenerative medicine, and advanced delivery platforms. He has also contributed to decentralized biotech initiatives through VitaDAO. Earlier in his career, Gunner held roles in banking and development finance at Bank of America Merrill Lynch, the European Bank for Reconstruction and Development, and the World Bank. Gunner holds dual Master of Science degrees in Biotechnology and in Economics and Finance, and dual bachelor’s degrees from Arizona State University’s Barrett Honors College. His academic work focused on bioinformatics, multi omics analysis, and plant sciences, alongside quantitative training in econometrics and Bayesian modeling.
Sessions
-
Investing in the Future of Cardiometabolic and Longevity Therapies: Differentiating Pipelines02-Mar-2026Pompeii Ballroom
-
Investing in the Future of Cardiometabolic and Longevity Therapies: Differentiating Pipelines02-Mar-2026Pompeii Ballroom
){kind=logo}
)
)
){kind=logo}
)
)
){kind=logo}
){kind=logo}
){kind=logo}
){kind=logo}
